Clinical trial Recruiting at 1 site Observational Ages 8 to 15

Real-life effects of medication and group therapy for ADHD and disruptive behaviors

Official title: Assessing Real Life Effectiveness of Treatment in Neurodevelopmental Disorders

Run by IRCCS Eugenio Medea · NCT07273695 · Data updated 2026-11-12

This project will test whether methylphenidate and/or group psychotherapy help children and adolescents (ages 8–15) with ADHD and emotional or behavioral dysregulation.

More Oppositional Defiant Disorder trials

Quick facts

Study typeObservational
Ages8 Years to 15 Years
SexAll
Enrollment80 (estimated)
SponsorIRCCS Eugenio Medea
Academic / other
Locations1 site (Bosisio Parini, Lecco)
StatusRecruiting
StartedSeptember 19, 2025
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedDecember 9, 2025
Trial IDNCT07273695 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children and adolescents aged 8–15 with a clinical diagnosis of ADHD, externalizing disorder, and/or emotional dysregulation and an IQ ≥ 75 are the intended participants.

Probably not a fit

Children with IQ below 75, active psychosis, significant neurological disease (including epilepsy), substance abuse, or certain genetic syndromes are unlikely to be appropriate or to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter observational project follows children and adolescents (8–15) with ADHD, externalizing disorders, or emotional dysregulation who receive pharmacological (methylphenidate) and/or group psychotherapeutic treatments. Participants undergo multimodal assessments including clinical scales, behavioral tests, and neural measures before and after treatment, with both prospective and retrospective data collection. The design is non-randomized and non-blinded and compares real-world responses to medication versus group psychotherapy to measure symptom changes. Analyses will seek associations between individual characteristics and treatment responses to generate predictive profiles that could guide more personalized interventions.

Why it matters

Potential benefit: If successful, the project could help clinicians match children to medication or group therapy that is more likely to reduce ADHD and behavioral dysregulation symptoms.

How similar studies have gone: Randomized trials have shown methylphenidate reliably reduces core ADHD symptoms and some behavioral problems, group psychotherapies have shown mixed but promising effects, and using multimodal neural and behavioral measures to predict individual treatment response is a growing but still exploratory approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* Children and adolescents aged 8-15 years;
* Diagnosis of externalizing disorder, ADHD, and/or emotional dysregulation (assessed with questionnaires, interviews, and/or clinical observation);
* Intelligence quotient ≥ 75.

Exclusion Criteria

* IQ \< 75;
* Substance abuse and addictions;
* Psychosis;
* Acute disorders;
* Organic brain disorders;
* Presence of neurological diseases, epilepsy;
* Genetic syndromes;
* Co-diagnosis with other psychiatric or neurodevelopmental disorders (e.g., autism, anxiety, depression, etc.) and prior psychopharmacological therapy will not be considered exclusion criteria but will be recorded and declared.

Where it's running

  • IRCCS E Medea Scientific Institute - Asssociazione La Nostra Famiglia
    Bosisio Parini, Lecco, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.